Skip to content
TrialScanner

NCT02247037

Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer

No phase registeredCompletedCSBRCollaborator

Registry record

Lead sponsor
Icahn School of Medicine at Mount Sinai
Conditions
Triple Negative Breast Cancer
Primary completion
Jan 22, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02247037 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02247037: Patient-derived Xenograft... | TrialScanner